Breaking News Instant updates and real-time market news.

NVS

Novartis

$75.68

0.13 (0.17%)

05:41
03/21/17
03/21
05:41
03/21/17
05:41

Novartis says Cosentyx may modify course of moderate-to- severe psoriasis

Novartis announced new data suggesting, for the first time, that Cosentyx may modify the course of moderate-to-severe psoriasis leading to long-term, treatment-free skin clearance. Cosentyx is the first and only IL-17A inhibitor to have reported this potential of disease modification. These data were presented at the 13th Annual Maui Derm for Dermatologists 2017, Maui, Hawaii at which Novartis presented 14 abstracts. Following one year of treatment with Cosentyx, patients were randomized to either continuous treatment or treatment cessation until relapse. Patients with continuous treatment maintained their high level of response. Among the patients that discontinued treatment, 21% of psoriasis patients maintained skin clearance for up to one year without treatment and 10% maintained skin clearance after two years without treatment. Patients with longer disease duration were more likely to relapse, suggesting that early intervention increases the chance of remaining relapse free.

  • 26

    Jun

NVS Novartis
$75.68

0.13 (0.17%)

03/07/17
SOCG
03/07/17
UPGRADE
SOCG
Buy
Novartis upgraded to Buy from Hold at Societe Generale
03/07/17
LEHM
03/07/17
INITIATION
LEHM
Underweight
Novartis reinstated with an Underweight at Barclays
Barclays analyst Emmanuel Papadakis reinstated Novo Nordisk with an Underweight rating.
03/07/17
LEHM
03/07/17
NO CHANGE
LEHM
European Pharma raised to Positive from Neutral at Barclays
Barclays analyst Emmanuel Papadakis rolled out coverage of the European Pharmaceuticals space and upgraded his sector view to Positive from Neutral. The analyst has "high conviction that the recent transformational era of R&D innovation is set to continue," which he believes will allow the sector to retain pricing power. Papadakis put Overweight ratings on AstraZeneca (AZN), Roche (RHHBY) and Shire (SHPG), with Astra his top pick. The analyst put an Equal Weight rating on GlaxoSmithKline (GSK) and Underweight ratings on Sanofi (SNY), Novartis (NVS) and Novo Nordisk (NVO).
03/14/17
LEER
03/14/17
NO CHANGE
LEER
Monitoring requests put Novartis Kisqali at marketing disadvantage, says Leerink
Leerink analyst Seamus Fernandez notes that Novartis (NVS) announced the FDA approval of its CDK4/6 inhibitor Kisqali in combination with an aromatase inhibitor for the first-line treatment of post-menopausal women with hormone-receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer. The analyst says that the label contains warnings for QT prolongation as well as liver toxicity, both of which necessitate frequent monitoring. Although Kisqali appears to have similar efficacy to Pfizer (PFE) approved Ibrance, the latter's label does not include these warnings or monitoring requirements, he points out, adding that he continues to see Ibrance maintaining long-term market dominance in the CDK4/6 class.

TODAY'S FREE FLY STORIES

SLM

Sallie Mae

$11.47

0.21 (1.87%)

16:33
10/18/17
10/18
16:33
10/18/17
16:33
Earnings
Sallie Mae reports Q3 EPS 17c, consensus 17c »

Reports Q3 net interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

UAL

United Continental

$67.99

0.48 (0.71%)

16:32
10/18/17
10/18
16:32
10/18/17
16:32
Hot Stocks
Breaking Hot Stocks news story on United Continental »

United Continental sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

CCI

Crown Castle

$100.96

-0.42 (-0.41%)

16:32
10/18/17
10/18
16:32
10/18/17
16:32
Hot Stocks
Crown Castle raises quarterly dividend to $1.05 from 95c »

The quarterly dividend…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GHL

Greenhill & Co.

$17.10

0.05 (0.29%)

16:32
10/18/17
10/18
16:32
10/18/17
16:32
Hot Stocks
Greenhill & Co. 'substantially' reduces dividend to 5c per share »

"In order to improve…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

KALU

Kaiser Aluminum

$104.26

0.84 (0.81%)

16:32
10/18/17
10/18
16:32
10/18/17
16:32
Earnings
Kaiser Aluminum reports Q3 adjusted EPS 90c, consensus $1.08 »

Reports Q3 revenue $333M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

UAL

United Continental

$67.99

0.48 (0.71%)

16:32
10/18/17
10/18
16:32
10/18/17
16:32
Hot Stocks
Breaking Hot Stocks news story on United Continental »

United Continental sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

UAL

United Continental

$67.99

0.48 (0.71%)

16:31
10/18/17
10/18
16:31
10/18/17
16:31
Hot Stocks
Breaking Hot Stocks news story on United Continental »

United Continental sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

CCI

Crown Castle

$100.96

-0.42 (-0.41%)

16:30
10/18/17
10/18
16:30
10/18/17
16:30
Earnings
Crown Castle sees FY18 AFFO $2.22B-$2.26B »

Sees FY18 site rental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
10/18/17
10/18
16:30
10/18/17
16:30
Options
Preliminary option volume of 16.8M today »

Preliminary option volume…

RXDX

Ignyta

$16.25

1.9 (13.24%)

16:29
10/18/17
10/18
16:29
10/18/17
16:29
Syndicate
Ignyta announces $125M common stock offering »

Ignyta anticipates using…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 06

    Nov

CCI

Crown Castle

$100.96

-0.42 (-0.41%)

16:28
10/18/17
10/18
16:28
10/18/17
16:28
Earnings
Crown Castle sees Q4 AFFO $430M-$435M »

Sees Q4 site rental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEGI

Pattern Energy

16:28
10/18/17
10/18
16:28
10/18/17
16:28
Syndicate
Pattern Energy files to sell 8M shares of Class A common stock »

The offering is being…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USAP

Universal Stainless & Alloy

$21.12

-0.33 (-1.54%)

16:27
10/18/17
10/18
16:27
10/18/17
16:27
Hot Stocks
Breaking Hot Stocks news story on Universal Stainless & Alloy »

Universal Stainless &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDN

Brandywine Realty

$17.93

-0.02 (-0.11%)

16:26
10/18/17
10/18
16:26
10/18/17
16:26
Hot Stocks
Brandywine Realty announces joint venture disposition »

"In addition to the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 14

    Dec

RXDX

Ignyta

$16.25

1.9 (13.24%)

16:25
10/18/17
10/18
16:25
10/18/17
16:25
Syndicate
Breaking Syndicate news story on Ignyta »

Ignyta files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 06

    Nov

NTB

Butterfield

$35.81

0.29 (0.82%)

16:25
10/18/17
10/18
16:25
10/18/17
16:25
Hot Stocks
Butterfield chief risk officer Frumkin named COO »

The Bank of N.T.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 15

    Nov

VSEC

VSE Corp.

$58.21

0.01 (0.02%)

16:25
10/18/17
10/18
16:25
10/18/17
16:25
Hot Stocks
VSE Corp. awarded $35.6M in new delivery order awards »

VSE Corporation was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$153.00

2.62 (1.74%)

16:25
10/18/17
10/18
16:25
10/18/17
16:25
Conference/Events
Adobe to hold a briefing »

Financial Analyst and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 22

    Oct

  • 06

    Nov

HXL

Hexcel

$58.94

0.39 (0.67%)

16:24
10/18/17
10/18
16:24
10/18/17
16:24
Earnings
Hexcel narrows FY17 EPS guidance to $2.64-$2.72 from $2.64-$2.76 »

Consensus $2.68. Sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$67.99

0.48 (0.71%)

16:24
10/18/17
10/18
16:24
10/18/17
16:24
Hot Stocks
United Continental says Q3 pre-tax income reduced by about $185M due to storms »

During the quarter, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

BDN

Brandywine Realty

$17.93

-0.02 (-0.11%)

16:24
10/18/17
10/18
16:24
10/18/17
16:24
Earnings
Brandywine Realty sees FY18 EPS of 34c-44c, consensus 25c »

Announces 2018 FFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 14

    Dec

CCI

Crown Castle

$101.03

-0.315 (-0.31%)

16:23
10/18/17
10/18
16:23
10/18/17
16:23
Earnings
Crown Castle reports Q3 adjusted EPS 21c, consensus 24c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSC

TriState Capital

$22.75

-0.2 (-0.87%)

16:23
10/18/17
10/18
16:23
10/18/17
16:23
Earnings
TriState Capital reports Q3 EPS 35c, consensus 30c »

Reprots Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 06

    Nov

TBK

Triumph Bancorp

$31.80

0.25 (0.79%)

16:23
10/18/17
10/18
16:23
10/18/17
16:23
Earnings
Triumph Bancorp reports Q3 EPS 47C, consensus 44C »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 15

    Nov

BDN

Brandywine Realty

$17.93

-0.02 (-0.11%)

16:23
10/18/17
10/18
16:23
10/18/17
16:23
Earnings
Brandywine Realty raises FY17 EPS view to 72c-74c from 17c-21c »

Consensus 24c. Adjusting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 14

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.